RxSight, Inc.
RXST
26 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sep 3 1:45 AM | Kurtz Ronald M MD | Proposed Sale | 5,100 | $6.96 | $35.5K | — | View → |
| Sep 2, 2026 | Sep 3 1:43 AM | Wilterding Mark | Proposed Sale | 7,765 | $6.96 | $54.0K | — | View → |
| Sep 2, 2026 | Sep 3 1:40 AM | Goldshleger Ilya | Proposed Sale | 2,041 | $6.96 | $14.2K | — | View → |
| Sep 2, 2026 | Sep 3 1:38 AM | Weinberg Eric | Proposed Sale | 2,041 | $6.96 | $14.2K | — | View → |
| Sep 2, 2026 | Sep 3 1:35 AM | Ronald M Kurtz MDChief Medical Officer | Sale | 5,100 | $6.96 | $35.5K | 71,775(D) | View → |
| Sep 2, 2026 | Sep 3 1:35 AM | Mark WilterdingChief Financial Officer | Sale | 7,765 | $6.96 | $54.0K | 25,049(D) | View → |
| Sep 2, 2026 | Sep 3 1:34 AM | Ilya GoldshlegerChief Operating Officer | Sale | 2,041 | $6.96 | $14.2K | 81,509(D) | View → |
| Sep 2, 2026 | Sep 3 1:33 AM | Eric WeinbergChief Business Development Officer | Sale | 2,041 | $6.96 | $14.2K | 200,348(D) | View → |
| Aug 18, 2026 | Aug 18 9:45 PM | RAYMOND W COHEN | Proposed Sale | 11,890 | $6.37 | $75.7K | — | View → |
| Mar 12, 2025 | Mar 12 8:02 PM | TAMARA R FOUNTAIN | Proposed Sale | 7,000 | $25.71 | $180.0K | — | View → |
| Jan 22, 2025 | Jan 22 8:56 PM | Maniar Shweta | Proposed Sale | 3,519 | $30.87 | $108.6K | — | View → |
| Nov 29, 2024 | Nov 29 6:29 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,105 | $46.08 | $143.1K | — | View → |
| Nov 26, 2024 | Nov 26 9:13 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $45.88 | $142.2K | — | View → |
| Nov 26, 2024 | Nov 26 7:45 PM | Maniar Shweta | Proposed Sale | 3,782 | $45.88 | $173.5K | — | View → |
| Nov 22, 2024 | Nov 22 9:15 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $45.00 | $139.5K | — | View → |
| Nov 18, 2024 | Nov 18 9:29 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $45.00 | $139.5K | — | View → |
| Nov 15, 2024 | Nov 15 9:18 PM | ILYA GOLDSHLEGER | Proposed Sale | 4,875 | $46.00 | $224.3K | — | View → |
| Nov 7, 2024 | Nov 7 9:14 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $55.00 | $170.5K | — | View → |
| Oct 30, 2024 | Oct 30 8:28 PM | LYA GOLDSHLEGER | Proposed Sale | 3,105 | $51.91 | $161.2K | — | View → |
| Oct 28, 2024 | Oct 28 8:15 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $50.64 | $157.0K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 16 8:25 PM | Eric WeinbergChief Business Development Officer | Option Exercise | 35,168 | $4.34 | 0(D) | View → |
| Sep 5, 2026 | Sep 10 12:55 AM | Mark WilterdingChief Financial Officer | Disposition | 258,770 | $10.09 | 0(D) | View → |
| Sep 5, 2026 | Sep 10 12:55 AM | Mark WilterdingChief Financial Officer | Grant/Award | 258,770 | $6.38 | 258,770(D) | View → |
| Sep 5, 2026 | Sep 10 12:55 AM | Eric WeinbergChief Business Development Officer | Disposition | 449,637 | $56.07 | 0(D) | View → |
| Sep 5, 2026 | Sep 10 12:55 AM | Eric WeinbergChief Business Development Officer | Grant/Award | 334,075 | $6.38 | 93,984(D) | View → |
| Sep 5, 2026 | Sep 10 12:53 AM | Ronald M Kurtz MDChief Medical Officer | Grant/Award | 686,447 | $6.38 | 161,654(D) | View → |
| Sep 5, 2026 | Sep 10 12:53 AM | Ronald M Kurtz MDChief Medical Officer | Disposition | 902,819 | $56.07 | 0(D) | View → |
| Sep 5, 2026 | Sep 10 12:53 AM | Ilya GoldshlegerChief Operating Officer | Grant/Award | 364,032 | $6.38 | 93,984(D) | View → |
| Sep 5, 2026 | Sep 10 12:53 AM | Ilya GoldshlegerChief Operating Officer | Disposition | 485,567 | $56.07 | 0(D) | View → |
| Aug 31, 2026 | Sep 3 1:35 AM | Ronald M Kurtz MDChief Medical Officer | Option Exercise | 13,425 | — | 67,120(D) | View → |
| Aug 31, 2026 | Sep 3 1:35 AM | Mark WilterdingChief Financial Officer | Option Exercise | 20,441 | — | 122,646(D) | View → |
| Aug 31, 2026 | Sep 3 1:34 AM | Ilya GoldshlegerChief Operating Officer | Option Exercise | 5,370 | — | 26,848(D) | View → |
| Aug 31, 2026 | Sep 3 1:33 AM | Eric WeinbergChief Business Development Officer | Option Exercise | 5,370 | — | 26,848(D) | View → |
| Jul 24, 2026 | Jul 25 12:07 AM | Aziz MottiwalaDirector, President and CEO | Grant/Award | 2,883,424 | $5.19 | 571,286(D) | View → |
| Apr 17, 2026 | Apr 20 8:19 PM | Ilya GoldshlegerChief Operating Officer | Option Exercise | 12,489 | $4.13 | 5(D) | View → |
| Feb 28, 2026 | Mar 4 1:24 AM | Mark WilterdingChief Financial Officer | Option Exercise | 20,441 | — | 143,087(D) | View → |
| Feb 28, 2026 | Mar 4 1:22 AM | Scott GainesChief Customer Officer | Option Exercise | 6,261 | — | 2,500(D) | View → |
| Feb 27, 2026 | Mar 4 1:22 AM | Scott GainesChief Customer Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:21 AM | Ilya GoldshlegerChief Operating Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:20 AM | Eric WeinbergExhibit 24 - Power of Attorney Chief Business Development Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
Page 1 of 2
Next →